Holly Shill is a Neurology physician affiliated with Barrow Neurological Institute. OpenAlex indexes 275 publications with 15,764 citations (h-index 65). By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
240 W Thomas Rd # 301
Phoenix, AZ 85013
Telephone
602-406-6262Registry record last updated 14 Sept 2018.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ACADIA Pharmaceuticals IncProgram year20253 payments
- Sumitomo Pharma America, Inc.Program year20251 payment
- Neurocrine BioSciences, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
86.1%Neuromuscular Blocker86%Onabotulinumtoxina100%Part B, office-administered≥41 patientsMuscle Relaxant0.1%Cyclobenzaprine Hcl100%Part D<11 patientsNervous system
13.3%Aromatic Amino Acid Decarboxylation Inhibitor4.9%Carbidopa-Levodopa68%Carbidopa-Levodopa Er22%Rytary10%Part D≥223 patientsInfluenza A M2 Protein Inhibitor1.5%Amantadine82%Gocovri18%Part D<11 patients+ 19 more classes in this area
Cardiovascular
0.4%Beta blocker0.2%Propranolol Hcl Er56%Propranolol Hcl44%Part D<11 patientsalpha-Adrenergic Agonist0.1%Midodrine Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2002–2003 per NIH RePORTER. The latest:
- Parkinson's Disease Neuroprotection Trial
St. Joseph'S Hospital and Medical Center
FY2003$137,078U10NS044458 - Parkinson's Disease Neuroprotection Trial
St. Joseph'S Hospital and Medical Center
FY2002$137,078U10NS044458
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lawton, MD
Barrow Neurological Institute
Marwan Sabbagh, MD
Barrow Neurological Institute
Yonas Geda, MD, MSc
Barrow Neurological Institute
Nader Sanai, MD
Barrow Neurological Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”